Successful completion of the sale of the Carragelose business Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals All requirements for closing the... View Article
Rare Disease Day Rare Disease Day: A Call for Innovation in Pharmaceutical Development Marianne Henrion is R&D Site Director at Unither Pharmaceuticals since... View Article
From early stages of ophthalmic product development Unither’s CDMO supports its customers from early stages of ophthalmic product development Anaïs CASTEX holds a Master’s degree in Formulation... View Article
Whitepaper: Carragelose® Eye Drops Download the Whitepaper: Carragelose® Eye Drops A Novel Approach to Dry Eye Disease Treatment This whitepaper presents an in-depth analysis... View Article
Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division PRESS RELEASE Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division Required majority of shareholders vote in... View Article
Launch of our first commercial batches of PFMD PRESS RELEASE Unither Pharmaceuticals launches first commercial batches of Preservative-Free Multidose Ophthalmic products Coutances, France – [December 11,... View Article
Press Release – Acquisition of the Carragelose Portfolio by Unither Pharmaceuticals Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals Marinomed to sell Carragelose... View Article
Advanced liquid solutions for better patient outcomes Flexible Packaging and Delivery Systems for the OTC Market Unither Pharmaceuticals provides a wide range of customizable liquid delivery systems,... View Article
